financetom
Business
financetom
/
Business
/
BXP Completes Three-Way Venture for Development of $400 Million Jersey City Residential Project
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BXP Completes Three-Way Venture for Development of $400 Million Jersey City Residential Project
Mar 6, 2025 5:29 AM

08:03 AM EST, 03/06/2025 (MT Newswires) -- BXP (BXP) said Thursday it has completed the formation of a joint venture to develop 290 Coles Street, a 1.75-acre site in Jersey City, New Jersey, into a 670-unit residential project.

BXP said it and its partners will execute the approximately $400 million development through a newly formed venture with CrossHarbor Capital, Albanese Organization and its partner.

Under the terms of the agreement, BXP said it will own a 19% interest in the venture, Albanese 14%, CrossHarbor Capital the remaining 67%.

BXP will also provide $65 million in preferred equity as additional project funding, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Tech Group Cautions Biden Administration Against Rule Meant to Curtail International Access to AI Chips
Market Chatter: Tech Group Cautions Biden Administration Against Rule Meant to Curtail International Access to AI Chips
Jan 8, 2025
08:28 AM EST, 01/08/2025 (MT Newswires) -- A tech group representing companies like Amazon ( AMZN ) , Microsoft ( MSFT ) , and Meta (META) called on the Biden administration to avoid implementing a rule that would curtail international access to AI chips, Reuters reported Tuesday, citing the group's letter to US Commerce Secretary Gina Raimondo. The Information Technology...
Halozyme Therapeutics Raises 2025 Guidance; Shares Up Pre-Bell
Halozyme Therapeutics Raises 2025 Guidance; Shares Up Pre-Bell
Jan 8, 2025
08:23 AM EST, 01/08/2025 (MT Newswires) -- Halozyme Therapeutics ( HALO ) shares were 5% higher premarket Wednesday after the company raised its 2025 adjusted earnings per share and revenue guidance driven by higher royalty revenue and increased product sales from its Xyosted treatment. The company now expects adjusted earnings per share for 2025 to range from $4.95 to $5.35,...
UniFirst Fiscal Q1 Earnings, Revenue Increase
UniFirst Fiscal Q1 Earnings, Revenue Increase
Jan 8, 2025
08:28 AM EST, 01/08/2025 (MT Newswires) -- UniFirst ( UNF ) reported fiscal Q1 earnings Wednesday of $2.31 per diluted share, up from $2.26 a year earlier. Three analysts polled by FactSet expected $2.09. Revenue for the fiscal quarter ended Nov. 30 was $604.9 million, up from $593.5 million a year earlier. Three analysts surveyed by FactSet expected $606.6 million....
Calibre Books Record Q4 Gold Production, Beats Full-Year Production Guidance
Calibre Books Record Q4 Gold Production, Beats Full-Year Production Guidance
Jan 8, 2025
08:25 AM EST, 01/08/2025 (MT Newswires) -- Calibre Mining ( CXBMF ) on Wednesday reported record gold production in the fourth quarter, which helped the company beat its full-year guidance. The company produced 76,269 ounces of gold at its mines in Nicaragua and Nevada, pushing the full-year 2024 total output to 242,487 ounces. Calibre had forecast 2024 production at between...
Copyright 2023-2026 - www.financetom.com All Rights Reserved